127 related articles for article (PubMed ID: 37652486)
1. Orthotopic Mouse Models of Urinary Bladder Cancer.
Noh JI; Ahn EJ; Noh MG; Moon KS; Chung E; Choi C; Lee KH; Kim SS
In Vivo; 2023; 37(5):2039-2043. PubMed ID: 37652486
[TBL] [Abstract][Full Text] [Related]
2. An orthotopic xenograft model for high-risk non-muscle invasive bladder cancer in mice: influence of mouse strain, tumor cell count, dwell time and bladder pretreatment.
Huebner D; Rieger C; Bergmann R; Ullrich M; Meister S; Toma M; Wiedemuth R; Temme A; Novotny V; Wirth MP; Bachmann M; Pietzsch J; Fuessel S
BMC Cancer; 2017 Nov; 17(1):790. PubMed ID: 29169339
[TBL] [Abstract][Full Text] [Related]
3. [Establishment and application of an orthotopic murine bladder cancer model].
Yang SM; Wen DG; Hou JQ; He J; Cen JN; Chen JH
Ai Zheng; 2007 Apr; 26(4):341-5. PubMed ID: 17430648
[TBL] [Abstract][Full Text] [Related]
4. Optimizing orthotopic bladder tumor implantation in a syngeneic mouse model.
Chan ES; Patel AR; Smith AK; Klein JB; Thomas AA; Heston WD; Larchian WA
J Urol; 2009 Dec; 182(6):2926-31. PubMed ID: 19846165
[TBL] [Abstract][Full Text] [Related]
5. Establishment of orthotopic mouse superficial bladder tumor model for studies on intravesical treatments.
Horiguchi Y; Kikuchi E; Ozu C; Nishiyama T; Oyama M; Horinaga M; Yoshioka K; Tachibana M
Hum Cell; 2008 Aug; 21(3):57-63. PubMed ID: 18667021
[TBL] [Abstract][Full Text] [Related]
6. Intravesical interleukin-15 gene therapy in an orthotopic bladder cancer model.
Matsumoto K; Kikuchi E; Horinaga M; Takeda T; Miyajima A; Nakagawa K; Oya M
Hum Gene Ther; 2011 Nov; 22(11):1423-32. PubMed ID: 21554107
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the immunologic mechanism of intravesical bacillus Calmette-Guerin therapy for superficial bladder tumors: distribution and function of immune cells.
Chung JY; Lee ES; Lee WJ; Kim HH; Min KJ; Lee C
J Korean Med Sci; 1993 Apr; 8(2):135-44. PubMed ID: 8397930
[TBL] [Abstract][Full Text] [Related]
8. EDTA-induced urothelial cell shedding for the treatment of superficial bladder cancer in the mouse.
Nativ O; Dalal E; Hidas G; Aronson M
Int J Urol; 2006 Oct; 13(10):1344-6. PubMed ID: 17010016
[TBL] [Abstract][Full Text] [Related]
9. [A model of orthotopic transplantation in mice using MBT-2].
Sasaki A; Miyanaga N; Ohtani M; Koiso K; Nemoto R; Takanashi R
Nihon Hinyokika Gakkai Zasshi; 1991 Sep; 82(9):1461-5. PubMed ID: 1942706
[TBL] [Abstract][Full Text] [Related]
10. How cancer cells attach to urinary bladder epithelium in vivo: study of the early stages of tumorigenesis in an orthotopic mouse bladder tumor model.
Erman A; Kapun G; Novak S; Pavlin M; Dražić G; Drobne D; Veranič P
Histochem Cell Biol; 2019 Mar; 151(3):263-273. PubMed ID: 30280243
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis and management of superficial bladder cancer.
Amling CL
Curr Probl Cancer; 2001; 25(4):219-78. PubMed ID: 11514784
[TBL] [Abstract][Full Text] [Related]
12. Magnetic resonance imaging for detecting and treatment monitoring of orthotopic murine bladder tumor implants.
Chin J; Kadhim S; Garcia B; Kim YS; Karlik S
J Urol; 1991 Jun; 145(6):1297-301. PubMed ID: 2033720
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of direct intramural injection to the bladder wall as a method for developing orthotopic tumor models.
Bitaraf M; Muhammadnejad S; Azimzadeh A; Tanourlouee SB; Amini E; Zolbin MM; Kajbafzadeh AM
Animal Model Exp Med; 2022 Dec; 5(6):575-581. PubMed ID: 36451547
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the efficacy of intravesical Bacillus Calmette-Guérin with thiotepa, mitomycin C, poly I:C/poly-L-lysine and cis platinum in murine bladder cancer.
Shapiro A; Ratliff TL; Oakley DM; Catalona WJ
J Urol; 1984 Jan; 131(1):139-42. PubMed ID: 6418894
[TBL] [Abstract][Full Text] [Related]
15. Intravesical oncolytic virotherapy and immunotherapy for non-muscle-invasive bladder cancer mouse model.
Smelser WW; Wang J; Ogden KM; Chang SS; Kirschner AN
BJU Int; 2023 Sep; 132(3):298-306. PubMed ID: 36961272
[TBL] [Abstract][Full Text] [Related]
16. Establishment of Mouse Orthotopic Urinary Bladder Tumor Model and Its Analysis by Light and Electron Microscopy.
Erman A; Kamenšek U; Peskar D; Veranič P
Methods Mol Biol; 2024; 2773():33-49. PubMed ID: 38236534
[TBL] [Abstract][Full Text] [Related]
17. A model of orthotopic murine bladder (MBT-2) tumor implants.
Jiang F; Zhou XM
Urol Res; 1997; 25(3):179-82. PubMed ID: 9228669
[TBL] [Abstract][Full Text] [Related]
18. [A simple and efficient method for establishing a mouse model of orthotopic MB49 bladder cancer].
Liang ZK; Zhang L; Hu ZM; Chen Z; Huang X; Shi XH; Tan WL; Gao JM
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Apr; 29(4):627-30. PubMed ID: 19403380
[TBL] [Abstract][Full Text] [Related]
19. Chemoablation with Intensive Intravesical Mitomycin C Treatment: A New Approach for Non-muscle-invasive Bladder Cancer.
Racioppi M; Di Gianfrancesco L; Ragonese M; Palermo G; Sacco E; Bassi P
Eur Urol Oncol; 2019 Sep; 2(5):576-583. PubMed ID: 31411974
[TBL] [Abstract][Full Text] [Related]
20. How Cancer Cells Invade Bladder Epithelium and Form Tumors: The Mouse Bladder Tumor Model as a Model of Tumor Recurrence in Patients.
Erman A; Kamenšek U; Dragin Jerman U; Pavlin M; Čemažar M; Veranič P; Romih R
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34199232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
